• CTOP (SKU B5135): Reliable μ-Opioid Receptor Antagonist for

  2026-06-23

  This in-depth article addresses common laboratory challenges in opioid receptor studies, illustrating how CTOP (SKU B5135) provides robust, data-backed solutions for reproducibility and assay specificity. Integrating scenario-driven Q&A, it guides researchers through protocol optimization and product selection, firmly grounded in validated literature and best practices. CTOP's performance and reliability position it as a staple for μ-opioid receptor research.

• Chicken Gasdermins and Caspase Cleavage: New Insights into A

  2026-06-23

  This study elucidates the molecular mechanisms underlying pyroptosis in chickens by identifying gasdermin A (chGSDMA) and gasdermin E (chGSDME) as key mediators cleaved by specific avian caspases. The findings expand the understanding of inflammasome activation and regulated cell death in birds, with implications for infectious disease and immunology research.

• HOXC8 Suppresses Caspase-1-Driven Pyroptosis in Lung Cancer

  2026-06-22

  This study uncovers a crucial role for HOXC8 in non-small cell lung carcinoma (NSCLC), demonstrating that HOXC8 represses caspase-1 expression to prevent pyroptotic cell death. The findings reveal a new epigenetic regulatory axis with implications for tumor cell survival and pyroptosis-targeted research.

• Selective P2X1 Receptor Inhibition by NF449 in Platelet Func

  2026-06-22

  The reference study introduces NF449 as a highly selective antagonist of the platelet P2X1 receptor, enabling fine dissection of purinergic signaling in platelet activation and thrombosis. Its findings reveal that targeted P2X1 inhibition can reduce thrombus formation without significantly affecting hemostasis, offering a foundation for safer antithrombotic strategies.

• IgSF6 Deficiency Boosts Macrophage Antibacterial Activity vi

  2026-06-21

  The referenced study reveals that immunoglobulin superfamily member 6 (IgSF6), localized in the endoplasmic reticulum of intestinal macrophages, acts as a key regulator of ER stress and inflammatory responses. Loss of IgSF6 heightens macrophage bactericidal activity through the IRE1α/XBP1 signaling pathway, offering new insight into gut immune defense and homeostasis.

• HNRNPU K181 Lactylation Rewires Serine Metabolism in Cervica

  2026-06-20

  This study uncovers a novel metabolic regulatory axis in cervical cancer, demonstrating that lactylation of HNRNPU at lysine 181 stabilizes PHGDH mRNA and drives serine metabolic reprogramming. The findings establish a direct link between lactate-driven post-translational modification and tumor progression, offering new mechanistic insight and therapeutic targets for malignancy.

• KN-62 Enables Precision Inhibition of Calcium Signaling Path

  2026-06-19

  KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, empowers researchers to dissect CaMKII-driven cellular processes with unmatched selectivity. This article delivers actionable protocols, advanced troubleshooting, and evidence-driven insight for applied studies in metabolism, secretion, and cell cycle regulation.

• HNRNPU K181 Lactylation Drives Serine Metabolic Reprogrammin

  2026-06-19

  This study reveals that lactylation of HNRNPU at lysine 181 is a key regulatory event linking lactate accumulation to enhanced serine biosynthesis and cervical cancer growth. The findings highlight a dynamic post-translational modification switch that sustains PHGDH expression and promotes tumor progression, suggesting new avenues for therapeutic intervention.

• Quizartinib (AC220): Transforming FLT3 Inhibition in AML Res

  2026-06-18

  Quizartinib (AC220) stands apart as a highly selective FLT3 inhibitor, empowering acute myeloid leukemia (AML) researchers to design robust, resistance-aware experimental workflows. With best-in-class potency and validated in vivo efficacy, this APExBIO tool enables precision FLT3 signaling interrogation and translational modeling beyond conventional paradigms.

• Magneto-Piezoelectric Nanoparticles Enhance Bone Defect Repa

  2026-06-18

  This study introduces engineered magneto-piezoelectric nanoparticle scaffolds that simultaneously disrupt biofilms and activate oxidative phosphorylation in Icam1+ macrophages, promoting bone regeneration in infectious defects. By targeting the JAK2-STAT3 pathway, this approach offers a dual solution to infection control and bone healing, advancing the field of regenerative medicine.

• Z-YVAD-FMK: Decoding Caspase-1 Inhibition in Pyroptosis Rese

  2026-06-17

  Explore the scientific depth of Z-YVAD-FMK as a caspase-1 inhibitor, with a unique focus on its impact on pyroptosis mechanisms, assay optimization, and insights from gasdermin-mediated cell death studies. This article offers advanced analysis for apoptosis and inflammasome activation studies.

• Repurposing SERMs: Bazedoxifene’s Antimalarial Mechanism Exp

  2026-06-17

  This study demonstrates that bazedoxifene, a third-generation selective estrogen receptor modulator, exhibits potent antimalarial activity by inhibiting hemozoin formation in Plasmodium falciparum. These findings highlight the potential for clinically approved SERMs to be repurposed as adjunct therapies against malaria, especially in the face of growing drug resistance.

• Targeting BCL-XL and MCL-1 in Glioblastoma: Insights from BH

  2026-06-16

  This article examines recent evidence demonstrating elevated apoptotic priming in glioblastoma (GBM) due to increased expression of anti-apoptotic BCL-XL and MCL-1. The findings support the therapeutic vulnerability of GBM to BH3-mimetics, suggesting a rationale for selective BCL-XL inhibitor use in preclinical research and translational workflows.

• Pam3CSK4: Precision Neuro-Immune Modeling in Inflammation Re

  2026-06-16

  This article explores how Pam3CSK4, a synthetic TLR1/2 agonist, transforms the rigor and translational relevance of inflammatory disease models. We integrate mechanistic insights from emerging neuro-immune research—including the impact of TRPV1+ nerve stimulation on systemic inflammation—to guide strategic choices for experimental design in the next generation of immunology and neurobiology studies.

• Artesunate in Cancer Research: Precision Assay Design and Me

  2026-06-15

  Explore how Artesunate, a potent artemisinin derivative, transforms precision assay design for cancer research. This article uniquely integrates practical protocol guidance and mechanistic depth, offering new perspectives beyond standard reagent reviews.

15761 records 1/1051 page Next 12345 下5页 Last page